REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 151 filers reported holding REVANCE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,503,692 | -30.1% | 59,411 | -11.1% | 1.81% | -39.3% |
Q1 2023 | $2,152,433 | -35.5% | 66,825 | -63.0% | 2.98% | -6.9% |
Q4 2022 | $3,334,873 | -35.6% | 180,654 | -5.8% | 3.20% | -35.7% |
Q3 2022 | $5,180,000 | +179.4% | 191,868 | +43.0% | 4.98% | +146.8% |
Q2 2022 | $1,854,000 | -46.1% | 134,188 | -23.9% | 2.02% | -15.5% |
Q1 2022 | $3,439,000 | -15.2% | 176,336 | -29.0% | 2.39% | +22.7% |
Q4 2021 | $4,056,000 | -12.9% | 248,533 | +48.7% | 1.95% | -5.8% |
Q3 2021 | $4,658,000 | +1.6% | 167,191 | +8.1% | 2.07% | -2.3% |
Q2 2021 | $4,586,000 | +9.4% | 154,715 | +3.1% | 2.12% | -14.7% |
Q1 2021 | $4,193,000 | +65.6% | 150,013 | +67.9% | 2.48% | +28.4% |
Q4 2020 | $2,532,000 | – | 89,348 | – | 1.93% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |